TG Therapeutics, Inc. (TGTX)
31.40
+0.05
(+0.16%)
USD |
NASDAQ |
Dec 15, 16:00
31.41
+0.01
(+0.03%)
After-Hours: 20:00
TG Therapeutics Research and Development Expense (Annual): 94.29M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Amgen, Inc. | 5.676B |
| Karyopharm Therapeutics, Inc. | 142.89M |
| Axsome Therapeutics, Inc. | 186.54M |
| Krystal Biotech, Inc. | 53.57M |
| Arcutis Biotherapeutics, Inc. | 76.42M |